Literature DB >> 16716083

Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.

Fernanda Ricchelli1, Raffaella Buggio, Denise Drago, Mario Salmona, Gianluigi Forloni, Alessandro Negro, Giuseppe Tognon, Paolo Zatta.   

Abstract

In this study we investigated the role of Cu(2+), Mn(2+), Zn(2+), and Al(3+) in inducing defective conformational rearrangements of the recombinant human prion protein (hPrP), which trigger aggregation and fibrillogenesis. The research was extended to the fragment of hPrP spanning residues 82-146, which was identified as a major component of the amyloid deposits in the brain of patients affected by Gerstmann-Sträussler-Scheinker (GSS) disease. Variants of the 82-146 wild-type subunit [PrP-(82-146)(wt)] were also examined, including entirely, [PrP-(82-146)(scr)], and partially scrambled, [PrP-(82-146)(106)(-)(126scr)] and [PrP-(82-146)(127)(-)(146scr)], peptides. Al(3+) strongly stimulated the conversion of native hPrP into the altered conformation, and its potency in inducing aggregation was very high. Despite a lower rate and extent of prion protein conversion into altered isoforms, however, Zn(2+) was more efficient than Al(3+) in promoting organization of hPrP aggregates into well-structured, amyloid-like fibrillar filaments, whereas Mn(2+) delayed and Cu(2+) prevented the process. GSS peptides underwent the fibrillogenesis process much faster than the full-length protein. The intrinsic ability of PrP-(82-146)(wt) to form fibrillar aggregates was exalted in the presence of Zn(2+) and, to a lesser extent, of Al(3+), whereas Cu(2+) and Mn(2+) inhibited the conversion of the peptide into amyloid fibrils. Amino acid substitution in the neurotoxic core (sequence 106-126) of the 82-146 fragment reduced its amyloidogenic potential. In this case, the stimulatory effect of Zn(2+) was lower as compared to the wild-type peptide; on the contrary Al(3+) and Mn(2+) induced a higher propensity to fibrillation, which was ascribed to different binding modalities to GSS peptides. In all cases, alteration of the 127-146 sequence strongly inhibited the fibrillogenesis process, thus suggesting that integrity of the C-terminal region was essential both to confer amyloidogenic properties on GSS peptides and to activate the stimulatory potential of the metal ions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716083     DOI: 10.1021/bi0601454

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Aggregation of prion protein with insertion mutations is proportional to the number of inserts.

Authors:  Shuiliang Yu; Shaoman Yin; Chaoyang Li; Poki Wong; Binggong Chang; Fan Xiao; Shin-Chung Kang; Huimin Yan; Gengfu Xiao; Po Tien; Man-Sun Sy
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

2.  Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions.

Authors:  Abhay Kumar Thakur; Atul Kumar Srivastava; Volety Srinivas; Kandala Venkata Ramana Chary; Chintalagiri Mohan Rao
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

3.  Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments.

Authors:  Lucy L Liu; Katherine J Franz
Journal:  J Biol Inorg Chem       Date:  2006-11-03       Impact factor: 3.358

Review 4.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

5.  Interaction of selected divalent metal ions with human ataxin-3 Q36.

Authors:  Iwona Stawoska; Aleksandra Wesełucha-Birczyńska; Maria Elena Regonesi; Matteo Riva; Paolo Tortora; Grazyna Stochel
Journal:  J Biol Inorg Chem       Date:  2009-07-04       Impact factor: 3.358

6.  Phosphorylation of prion protein at serine 43 induces prion protein conformational change.

Authors:  Paresa N Giannopoulos; Catherine Robertson; Julie Jodoin; Hemant Paudel; Stephanie A Booth; Andrea C LeBlanc
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

7.  Mutual stimulation of beta-amyloid fibrillogenesis by clioquinol and divalent metals.

Authors:  Silvia Bolognin; Paolo Zatta; Denise Drago; Giuseppe Tognon; Pier Paolo Parnigotto; Fernanda Ricchelli
Journal:  Neuromolecular Med       Date:  2008-08-19       Impact factor: 3.843

Review 8.  Metal and complementary molecular bioimaging in Alzheimer's disease.

Authors:  Nady Braidy; Anne Poljak; Christopher Marjo; Helen Rutlidge; Anne Rich; Tharusha Jayasena; Nibaldo C Inestrosa; Perminder Sachdev
Journal:  Front Aging Neurosci       Date:  2014-07-15       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.